Benzinga | Nov 11, 2021 04:18PM EST

Iridex Q3 EPS $(0.14), Inline, Sales $13.30M Beat $11.90M Estimate; Raises FY21 Sales Guidance From $50M-$52M To $52M-$53M vs $51.5M Est.

Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.14) per share which met the analyst consensus estimate. This is a 16.67 percent decrease over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $13.30 million which beat the analyst consensus estimate of $11.90 million by 11.76 percent. This is a 51.08 percent increase over sales of $8.80 million the same period last year.